作者
Najmeh Bozorgmehr, Mark Hnatiuk, Anthea C Peters, Shokrollah Elahi
发表日期
2023/1/27
期刊
Experimental Hematology & Oncology
卷号
12
期号
1
页码范围
13
出版商
BioMed Central
简介
Background
CD8+ T cells play an essential role against tumors but the role of human CD8+CD26+ T cell subset against tumors, in particular, haematological cancers such as chronic lymphocytic leukemia (CLL) remains unknown. Although CD4+CD26high T cells are considered for adoptive cancer immunotherapy, the role of CD8+CD26+ T cells is ill-defined. Therefore, further studies are required to better determine the role of CD8+CD26+ T cells in solid tumors and haematological cancers.
Methods
We studied 55 CLL and 44 age-sex-matched healthy controls (HCs). The expression of CD26 on different T cell subsets (e.g. naïve, memory, effector, and etc.) was analyzed. Also, functional properties of CD8+CD26+ and CD8+CD26 T cells were evaluated. Finally, the plasma cytokine/chemokine and Galectin-9 (Gal-9) levels were examined.
Results
CD26 expression identifies three CD8+ T cell subsets with distinct …
引用总数
学术搜索中的文章